☆ 4.3 Article

Pharmacovigilance regulatory actions by national pharmacovigilance centers in Arab countries following COVID-19 pandemic

EXPERT OPINION ON DRUG SAFETY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Medical Informatics

Regulatory Flexibilities and Guidances for Addressing the Challenges of COVID-19 in the EU: What Can We Learn from Company Experiences?

Kevin Klein et al.

Summary: The COVID-19 pandemic created a need for urgent development and delivery of vaccines and therapeutics. In Europe, regulatory flexibilities were introduced mainly for COVID-19 vaccines, and later for therapeutics. A survey revealed that these flexibilities were seen as valuable beyond the pandemic, especially when EU and Member States collaborated closely.

THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2022)

添加到收藏夹

Article Medical Informatics

New Approaches to Regulatory Innovation Emerging During the Crucible of COVID-19 In Responding to a Global Health Crisis, Industry is Discovering New, Efficient Ways of Meeting Objectives

Max Wegner

Summary: The urgency and impact of the ongoing COVID-19 pandemic are changing global drug development and regulatory processes, with companies needing to implement new processes/tools to stay competitive and compliant, and regulatory agencies should consider a globally acceptable application platform to retain agility.

THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2021)

添加到收藏夹

Correction Public, Environmental & Occupational Health

Assessing the Safety of COVID-19 Vaccines: A Primer (vol 43, pg 1205, 2020)

Helen Petousis-Harris

Summary: This section discusses the conflicts of interest and competing interests.

DRUG SAFETY (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

A qualitative exploration of pharmacovigilance policy implementation in Jordan, Oman, and Kuwait using Matland's ambiguity-conflict model

Hamza Y. Garashi et al.

Summary: The study identified low policy ambiguity and conflict in policy implementation in Jordan and Oman, while Kuwait showed high ambiguity and varied perceptions of conflict. Factors such as decision-makers' guidance, stakeholder involvement, and clear implementation plans were found to reduce policy ambiguity in Jordan and Oman, while the absence of these factors contributed to policy ambiguity in Kuwait. Factors reducing policy conflict included compliance with international standards, fit with local capabilities, and stakeholder agreement on policy goals and means in Jordan and Oman. Adopting a stepwise approach to implementation was also identified as a factor in reducing policy conflict in Jordan.

GLOBALIZATION AND HEALTH (2021)

添加到收藏夹

Editorial Material Public, Environmental & Occupational Health

The Role of Pharmacovigilance and ISoP During the Global COVID-19 Pandemic

Rebecca E. Chandler et al.

DRUG SAFETY (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands

Linda Harmark et al.

DRUG SAFETY (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

National pharmacovigilance programs in Arab countries: A quantitative assessment study

Thamir M. Alshammari et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

The Impact of the COVID-19 Infodemic on Drug-Utilization Behaviors: Implications for Pharmacovigilance

Marco Tuccori et al.

DRUG SAFETY (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

Unique challenges to control the spread of COVID-19 in the Middle East

Zulqarnain Baloch et al.

JOURNAL OF INFECTION AND PUBLIC HEALTH (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

Health equity and COVID-19: global perspectives

Efrat Shadmi et al.

INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH (2020)

添加到收藏夹

Review Public, Environmental & Occupational Health

Pharmacovigilance Systems in Arab Countries: Overview of 22 Arab Countries

Thamir M. Alshammari et al.

DRUG SAFETY (2019)

添加到收藏夹

Article Public, Environmental & Occupational Health

Organizational capacities of national pharmacovigilance centres in Africa: assessment of resource elements associated with successful and unsuccessful pharmacovigilance experiences

H. Hilda Ampadu et al.

GLOBALIZATION AND HEALTH (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

Current state of pharmacovigilance in the Arab and Eastern Mediterranean region: results of a 2015 survey

Danya M. Qato

INTERNATIONAL JOURNAL OF PHARMACY PRACTICE (2018)

添加到收藏夹

Review Medical Informatics

How to promote adverse drug reaction reports using information systems - a systematic review and meta-analysis

Ines Ribeiro-Vaz et al.

BMC MEDICAL INFORMATICS AND DECISION MAKING (2016)

添加到收藏夹

Review Pharmacology & Pharmacy

Pharmacovigilance in resource-limited countries

Sten Olsson et al.

EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2015)

添加到收藏夹

Editorial Material Medicine, General & Internal

Pharmacovigilance bolstered in the Arab world

Syed Rizwanuddin Ahmad

LANCET (2014)

添加到收藏夹

Editorial Material Medicine, General & Internal

Drug Safety in the Digital Age

Thomas J. Hwang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.